FdaApplication

ANDA 090189

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2016-10-28

Products (1)

ProductActive ingredientStrengthDosage form
BIVALIRUDINBIVALIRUDIN250MG/VIALINJECTABLE;INTRAVENOUS

1 product